Edwards Lifesciences SVP Andrew M. Dahl Sells 544 Shares Under Employee Stock Purchase Plan

Andrew M. Dahl, Senior Vice President and Corporate Controller at Edwards Lifesciences Corp, sold 544 shares of common stock at $91.055 per share on August 31, 2026, under the company's Employee Stock Purchase Plan. Following this transaction, Dahl directly owns 14,868.41 shares of Edwards Lifesciences. This transaction was disclosed via an SEC Form 4 and reflects routine quarterly share acquisitions.